PuriBlood Medical Co (ROCO:6847) Tariff Resilience Score: 0/10 (As of Jul. 23, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

ROCO:6847 PuriBlood Medical Co Ltd ROCO:6847
73 GF Score
Price NT$75.00
GF Value NT$65.96
Valuation Modestly Overvalued
! 6 Warning Signs
View Full Analysis

What is PuriBlood Medical Co Tariff Resilience Score?

PuriBlood Medical Co has the Tariff Resilience Score of 0, which implies that the company might have .

PuriBlood Medical Co has

Tariff Resilience Score is a ranking system developed by GuruFocus to measure a company's exposure to international trade tariffs, rated on a scale from 0 to 10. It takes into account key factors such as global supply chain dependencies, manufacturing locations versus sales markets, import / export balance and percentage of revenue, and more.

The company's exposure to international trade tariffs based on these criteria:

1. Global supply chain dependencies
2. Manufacturing locations versus sales markets
3. Import/export balance and percentage of revenue
4. Historical impact from previous tariff changes
5. Available mitigation strategies (alternative suppliers, pricing power)
6. Industry-specific tariff exemptions or vulnerabilities

Based on the research, GuruFocus believes PuriBlood Medical Co might have .


PuriBlood Medical Co  (ROCO:6847) Tariff Resilience Score Explanation

The Tariff Resilience Score ranges from 0 to 10, with 10 as the most resilient. GuruFocus divided Moat Score into following 3 categories:

Tariff Resilience Score Resilience Level
7 - 10Highly Resilient
4 - 6Average Resilient
0 - 3Highly Vulnerable

PuriBlood Medical Co Tariff Resilience Score Related Terms

ROCO:6847
73GF Score
PuriBlood Medical Co Ltd ROCO:6847
Tariff Resilience Score is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is PuriBlood Medical Co (ROCO:6847) Overvalued in 2026?

Based on GuruFocus' analysis, PuriBlood Medical Co stock appears to be overvalued. The current stock price of NT$75.00 is trading 13.7% above its estimated GF Value™ of NT$65.96. GuruFocus considers PuriBlood Medical Co to be Modestly Overvalued.

Key valuation signals for ROCO:6847:

  • Tariff Resilience Score: 0
  • GF Value™: NT$65.96 vs. price of NT$75.00 (13.7% above fair value)
  • GF Score™: 73/100 with 6 warning signs

No single metric tells the full story. See the ROCO:6847 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


PuriBlood Medical Co Business Description

Address Gongye E. 9th Road, Baoshan Township, 2nd Floor, No.11, Hsinchu County, Baoshan, TWN
PuriBlood Medical Co Ltd is engaged in developing solutions for leukoreduction, cell separation, and anti-fouling materials. Its technology protects to supports living beings from medical devices to daily protection. The products of the company include Leukoreduction, Cell Separation, and P-tex.
73GF Score

Get the complete analysis for ROCO:6847

Tariff Resilience Score is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

NT$75.00
Price
NT$65.96
GF Value